Diamond-Blackfan Anemia: Diagnosis, Treatment, and Molecular Pathogenesis

Hematology/Oncology Clinics of North America

Volumn 23, Issue 2, 2009, Pages 261-282

  Lipton, Jeffrey M ^a,b,c   Ellis, Steven R ^d  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Cancer predisposition; Diamond Blackfan anemia; Inherited bone marrow failure syndrome; Pure red cell aplasia; Ribosome biogenesis

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; IRON CHELATING AGENT; PREDNISONE; PROTEIN MDM2; PROTEIN P53; RIBOSOMAL PROTEIN L5; RIBOSOMAL PROTEIN S19; RIBOSOME PROTEIN; STEROID; UNCLASSIFIED DRUG;

BIRTH DEFECT; BLACKFAN DIAMOND ANEMIA; BLOOD CELL; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; BREAST CANCER; CATARACT; CELL MATURATION; CLINICAL FEATURE; CUSHINGOID SYNDROME; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSERYTHROPOIESIS; ENZYME ACTIVITY; ERYTHROBLASTOPENIA; FANCONI ANEMIA; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MANDIBULOFACIAL DYSOSTOSIS; MEGALOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; STEM CELL TRANSPLANTATION;

ADRENAL CORTEX HORMONES; ANEMIA, DIAMOND-BLACKFAN; DISEASE SUSCEPTIBILITY; ERYTHROCYTE TRANSFUSION; HUMANS; NEOPLASMS; RIBOSOMES; STEM CELL TRANSPLANTATION;

EID: 62949245936     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.01.004     Document Type: Review

References (97)

1. Young N.S. Inherited bone marrow failure syndromes: introduction (1994), WB Saunders Company, Philadelphia
2. Gripp K.W., McDonald-McGinn D.M., La Rossa D., et al. Bilateral microtia and cleft palate in cousins with Diamond-Blackfan anemia. Am J Med Genet 101 (2001) 268-274
3. Lipton J.M., Federman N., Khabbaze Y., et al. Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol 23 (2001) 39-44
4. Dianzani I., and Loreni F. Diamond-Blackfan anemia: a ribosomal puzzle. Haematologica 93 (2008) 1601-1604
5. Josephs H. Anemia of infancy and early childhood. Medicine 15 (1936) 307-451
6. Diamond L.K., and Blackfan K.D. Hypoplastic anemia. Am J Dis Child 56 (1938) 464-467
7. Diamond L.K., Wang W.C., and Alter B.P. Congenital hypoplastic anemia. Adv Pediatr 22 (1976) 349-378
8. Glader B.E., Backer K., and Diamond L.K. Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia. N Engl J Med 309 (1983) 1486-1490
9. Vlachos A., Klein G.W., and Lipton J.M. The Diamond Blackfan Anemia Registry: tool for investigating the epidemiology and biology of Diamond-Blackfan anemia. J Pediatr Hematol Oncol 23 (2001) 377-382
10. Gustavsson P., Garelli E., Draptchinskaia N., et al. Identification of microdeletions spanning the Diamond-Blackfan anemia locus on 19q13 and evidence for genetic heterogeneity. Am J Hum Genet 63 (1998) 1388-1395
11. Draptchinskaia N., Gustavsson P., Andersson B., et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 21 (1999) 169-175
12. Orfali K.A., Ohene-Abuakwa Y., and Ball S.E. Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneity. Br J Haematol 125 (2004) 243-252
13. Vlachos A., Ball S., Dahl N., et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol 142 (2008) 859-876
14. Balaban E.P., Buchanan G.R., Graham M., et al. Diamond-Blackfan syndrome in adult patients. Am J Med 78 (1985) 533-538
15. Willig T.N., Niemeyer C.M., Leblanc T., et al. Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Societe d'Hematologie et d'Immunologie Pediatrique (SHIP), Gesellshaft fur Padiatrische Onkologie und Hamatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI). Pediatr Res 46 (1999) 553-561
16. Campagnoli M.F., Garelli E., Quarello P., et al. Molecular basis of Diamond-Blackfan anemia: new findings from the Italian registry and a review of the literature. Haematologica 89 (2004) 480-489
17. Ohga S., Mugishima H., Ohara A., et al. Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation. Int J Hematol 79 (2004) 22-30
18. Freedman M.H., Amato D., and Saunders E.F. Erythroid colony growth in congenital hypoplastic anemia. J Clin Invest 57 (1976) 673-677
19. Nathan D.G., Clarke B.J., Hillman D.G., et al. Erythroid precursors in congenital hypoplastic (Diamond-Blackfan) anemia. J Clin Invest 61 (1978) 489-498
20. Lipton J.M., Kudisch M., Gross R., et al. Defective erythroid progenitor differentiation system in congenital hypoplastic (Diamond-Blackfan) anemia. Blood 67 (1986) 962-968
21. Chan H.S., Saunders E.F., and Freedman M.H. Diamond-Blackfan syndrome. II. In vitro corticosteroid effect on erythropoiesis. Pediatr Res 16 (1982) 477-478
22. Matsson H., Davey E.J., Frojmark A.S., et al. Erythropoiesis in the Rps19 disrupted mouse: analysis of erythropoietin response and biochemical markers for Diamond-Blackfan anemia. Blood Cells Mol Dis 36 (2006) 259-264
23. Alter B.P., Gaston T., and Lipton J.M. Lack of effect of corticosteroids in W/Wv and S1/S1d mice: these strains are not a model for steroid-responsive Diamond-Blackfan anemia. Eur J Haematol 50 (1993) 275-278
24. Danilova N., Sakamoto K.M., and Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 112 (2008) 5228-5237
25. Uechi T., Nakajima Y., Chakraborty A., et al. Deficiency of ribosomal protein S19 during early embryogenesis leads to reduction of erythrocytes in a zebrafish model of Diamond-Blackfan anemia. Hum Mol Genet 17 (2008) 3204-3211
26. Farrar J.E., Nater M., Caywood E., et al. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood 112 (2008) 1582-1592
27. McGowan K.A., Li J.Z., Park C.Y., et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 40 (2008) 963-970
28. Ohene-Abuakwa Y., Orfali K.A., Marius C., et al. Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect. Blood 105 (2005) 838-846
29. Perdahl E.B., Naprstek B.L., Wallace W.C., et al. Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. Blood 83 (1994) 645-650
30. Tsai P.H., Arkin S., and Lipton J.M. An intrinsic progenitor defect in Diamond-Blackfan anaemia. Br J Haematol 73 (1989) 112-120
31. Ellis S.R., and Lipton J.M. Diamond Blackfan anemia: a disorder of red blood cell development. Curr Top Dev Biol 82 (2008) 217-241
32. Cmejla R., Cmejlova J., Handrkova H., et al. Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum Mutat 28 (2007) 1178-1182
33. Gazda H.T., Grabowska A., Merida-Long L.B., et al. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet 79 (2006) 1110-1118
34. Gazda H.T., Sheen M.R., Vlachos A., et al. Ribosomal Protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 83 (2008) 769-780
35. Idol R.A., Robledo S., Du H.Y., et al. Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol Dis 39 (2007) 35-43
36. Flygare J., Aspesi A., Bailey J.C., et al. Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood 109 (2007) 980-986
37. Choesmel V., Bacqueville D., Rouquette J., et al. Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood 109 (2007) 1275-1283
38. Jin A., Itahana K., O'Keefe K., et al. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 24 (2004) 7669-7680
39. Dai M.S., Zeng S.X., Jin Y., et al. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 24 (2004) 7654-7668
40. Marechal V., Elenbaas B., Piette J., et al. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol 14 (1994) 7414-7420
41. Lohrum M.A., Ludwig R.L., Kubbutat M.H., et al. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3 (2003) 577-587
42. Zhang Y., Wolf G.W., Bhat K., et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 23 (2003) 8902-8912
43. Held W.A., Ballou B., Mizushima S., et al. Assembly mapping of 30 S ribosomal proteins from Escherichia coli: further studies. J Biol Chem 249 (1974) 3103-3111
44. Hage A.E., and Tollervey D. A surfeit of factors: why is ribosome assembly so much more complicated in eukaryotes than bacteria?. RNA Biol 1 (2004) 10-15
45. Lam Y.W., Lamond A.I., Mann M., et al. Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr Biol 17 (2007) 749-760
46. Chen D., Zhang Z., Li M., et al. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 26 (2007) 5029-5037
47. Horn H.F., and Vousden K.H. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene 27 (2008) 5774-5784
48. Lindstrom M.S., Deisenroth C., and Zhang Y. Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions. Cell Cycle 6 (2007) 434-437
49. Maggi Jr. L.B., Kuchenruether M., Dadey D.Y., et al. Nucleophosmin serves as a rate-limiting nuclear export chaperone for the mammalian ribosome. Mol Cell Biol 28 (2008) 7050-7065
50. Brady S.N., Yu Y., Maggi Jr. L.B., et al. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol Cell Biol 24 (2004) 9327-9338
51. Cathie I.A.B. Erythrogenesis imperfecta. Arch Dis Child 25 (1950) 313-324
52. Aase Jm S.D. Congenital anemia and triphalangeal thumbs: a new syndrome. J Pediatr 74 (1969) 471-472
53. Alter B.P. Thumbs and anemia. Pediatrics 62 (1978) 613-614
54. Lipton J.M., Atsidaftos E., Zyskind I., et al. Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry. Pediatr Blood Cancer 46 (2006) 558-564
55. Teber O.A., Gillessen-Kaesbach G., Fischer S., et al. Genotyping in 46 patients with tentative diagnosis of Treacher Collins syndrome revealed unexpected phenotypic variation. Eur J Hum Genet 12 (2004) 879-890
56. Fazen L.E., Elmore J., and Nadler H.L. Mandibulo-facial dysostosis (Treacher-Collins syndrome). Am J Dis Child 113 (1967) 405-410
57. Lipton J.M. Diamond Blackfan anemia (1993), CRC Press, Boca Raton (FL)
58. Wise C.A., Chiang L.C., Paznekas W.A., et al. TCOF1 gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins syndrome throughout its coding region. Proc Natl Acad Sci U S A 94 (1997) 3110-3115
59. So R.B., Gonzales B., Henning D., et al. Another face of the Treacher Collins syndrome (TCOF1) gene: identification of additional exons. Gene 328 (2004) 49-57
60. Dixon J., Edwards S.J., Anderson I., et al. Identification of the complete coding sequence and genomic organization of the Treacher Collins syndrome gene. Genome Res 7 (1997) 223-234
61. Dixon M.J. Treacher Collins syndrome. Hum Mol Genet 5 Spec No (1996) 1391-1396
62. Valdez B.C., Henning D., So R.B., et al. The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci U S A 101 (2004) 10709-10714
63. Gonzales B., Henning D., So R.B., et al. The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation. Hum Mol Genet 14 (2005) 2035-2043
64. Dixon J., Brakebusch C., Fassler R., et al. Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome. Hum Mol Genet 9 (2000) 1473-1480
65. Jones N.C., Lynn M.L., Gaudenz K., et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med 14 (2008) 125-133
66. Alter B.P. Inherited bone marrow failure syndromes (2003), WB Saunders, Philadelphia
67. Yaris N., Erduran E., and Cobanoglu U. Hodgkin lymphoma in a child with Diamond Blackfan anemia. J Pediatr Hematol Oncol 28 (2006) 234-236
68. Janov A.J., Leong T., Nathan D.G., et al. Diamond-Blackfan anemia: natural history and sequelae of treatment. Medicine (Baltimore) 75 (1996) 77-78
69. Alter B.P., Greene M.H., Velazquez I., et al. Cancer in Fanconi anemia. Blood 101 (2003) 2072
70. Rosenberg P.S., Alter B.P., Link D.C., et al. Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol 140 (2008) 210-213
71. Lensch M.W., Rathbun R.K., Olson S.B., et al. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia. Leukemia 13 (1999) 1784-1789
72. Li J., Sejas D.P., Zhang X., et al. TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. J Clin Invest 117 (2007) 3283-3295
73. Lindstrom M.S., Jin A., Deisenroth C., et al. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol Cell Biol 27 (2007) 1056-1068
74. Pestov D.G., Strezoska Z., and Lau L.F. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 21 (2001) 4246-4255
75. Boon K., Caron H.N., van Asperen R., et al. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J 20 (2001) 1383-1393
76. Oskarsson T., and Trumpp A. The myc trilogy: lord of RNA polymerases. Nat Cell Biol 7 (2005) 215-217
77. Ruggero D., and Pandolfi P.P. Does the ribosome translate cancer?. Nat Rev Cancer 3 (2003) 179-192
78. Amsterdam A., Sadler K.C., Lai K., et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2 (2004) E139
79. Liu J.M., and Ellis S.R. Ribosomes and marrow failure: coincidental association or molecular paradigm?. Blood 107 (2006) 4583-4588
80. Morimoto K., Lin S., and Sakamoto K. The functions of RPS19 and their relationship to Diamond-Blackfan anemia: a review. Mol Genet Metab 90 (2007) 358-362
81. Palis J., and Segel G.B. Developmental biology of erythropoiesis. Blood Rev 12 (1998) 106-114
82. Weinberg R.S., He L.Y., and Alter B.P. Erythropoiesis is distinct at each stage of ontogeny. Pediatr Res 31 (1992) 170-175
83. Dessypris E.N., Krantz S.B., Roloff J.S., et al. Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children. Blood 59 (1982) 114-123
84. Gasser C. Aplastische anämie (cronische erythroblastophthise) und cortison. Schweiz Med Wochenschr 81 (1951) 1241-1242
85. Olivieri N.F., and Brittenham G.M. Iron-chelating therapy and the treatment of thalassemia. Blood 89 (1997) 739-761
86. Nisbet-Brown E., Olivieri N.F., Giardina P.J., et al. Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet 361 (2003) 1597-1602
87. Alter B.P., Kumar M., Lockhart L.L., et al. Pregnancy in bone marrow failure syndromes: Diamond-Blackfan anaemia and Shwachman-Diamond syndrome. Br J Haematol 107 (1999) 49-54
88. Vlachos A., Federman N., Reyes-Haley C., et al. Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Bone Marrow Transplant 27 (2001) 381-386
89. Roy V., Perez W.S., Eapen M., et al. Bone marrow transplantation for Diamond-Blackfan anemia. Biol Blood Marrow Transplant 11 (2005) 600-608
90. Kuliev A., Rechitsky S., Tur-Kaspa I., et al. Preimplantation genetics: improving access to stem cell therapy. Ann N Y Acad Sci 1054 (2005) 223-227
91. Wagner J.E., Kahn J.P., Wolf S.M., et al. Preimplantation testing to produce an HLA-matched donor infant. JAMA 292 (2004) 803-804 author reply 804
92. Wynn R.F., Grainger J.D., Carr T.F., et al. Failure of allogeneic bone marrow transplantation to correct Diamond-Blackfan anaemia despite haemopoietic stem cell engraftment. Bone Marrow Transplant 24 (1999) 803-805
93. Flygare J., Olsson K., Richter J., et al. Gene therapy of Diamond Blackfan anemia CD34(+) cells leads to improved erythroid development and engraftment following transplantation. Exp Hematol 36 (2008) 1428-1435
94. Pospisilova D., Cmejlova J., Hak J., et al. Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine. Haematologica 92 (2007) e66-e67
95. Anthony J.C., Yoshizawa F., Anthony T.G., et al. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 130 (2000) 2413-2419
96. Sakai D., and Trainor P.A. Treacher Collins syndrome: unmasking the role of Tcof1/treacle. Int J Biochem Cell Biol 41 (2009) 1229-1232
97. Ebert B.L., Pretz J., Bosco J., et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 451 (2008) 335-339